A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(7 sites)
United States
Yale, North Haven, Connecticut Johns Hopkins, Baltimore, Maryland Brigham and Women's Hospital, Boston, Massachusetts University of Massachusetts, Worcester, Massachusetts University of Buffalo, Buffalo, New York Cornell Weill Medical Center, New York, New York Thomas Jefferson University Hospital, Philadelphia, Pennsylvania Last updated October 2025